Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Rheumatology Reports|March 9, 2021
Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile MyositisTheonymfi Doudouliaki, Charalampia Papadopoulou, Claire T Deakin
Current Opinion in Molecular Therapeutics|October 2, 2010
The ethics of gene therapy: balancing the risksClaire T Deakin, Ian E Alexander, Ian Kerridge
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2009
Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?Claire T Deakin, Ian E Alexander, Ian Kerridge
Frontiers in Immunology|September 11, 2023
The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysisJames Greenan-Barrett, Samuel Aston, Claire T Deakin, et al.
Clinical Rheumatology|July 5, 2023
Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL datasetSabina Ciciriello, Geoffrey Littlejohn, Catherine O'Sullivan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2013
Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trialsClaire T Deakin, Ian E Alexander, Cliff A Hooker, et al.
Statistical Methods in Medical Research|June 8, 2017
Modelling disease activity in juvenile dermatomyositis: A Bayesian approachEh Pieter van Dijkhuizen, Claire T Deakin, Lucy R Wedderburn, et al.
Arthritis Research & Therapy|August 17, 2018
Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort studyE H Pieter van Dijkhuizen, Maria De Iorio, Lucy R Wedderburn, et al.
Pediatric Rheumatology Online Journal|September 26, 2021
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathologyMeredyth G Ll Wilkinson, Claire T Deakin, Charalampia Papadopoulou, et al.
Blood|March 17, 2007
Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptorsChristine M Smyth, Samantha L Ginn, Claire T Deakin, et al.
Pageof 4